Drug Residues in Milk and Milk Products Risk Assessment

Over the years, concern has been raised over the possibility of drug residues in dairy foods, such as fluid milk. The requirement to test milk and milk products for drug residues, is limited to only the Beta lactam drugs and has not changed over the past twenty years. For this reason, the National Conference on Interstate Milk Shipments (NCIMS) Drug Residue Committee has requested that FDA perform a risk assessment on potential drug residues in milk and milk products produced in the United States to re-evaluate the National Drug Residue Milk Monitoring Program. This symposium will describe the potential drug residue problem in milk and milk products and the approach utilized in analyzing this issue. The Drug Residues in Milk Risk Assessment Work Group consists of scientific and dairy experts from FDA, Center for Food Safety and Applied Nutrition (CFSAN) and Center for Veterinary Medicine (CVM) working together to develop a risk assessment on drug residues in raw milk and milk products.